Attached files
| file | filename |
|---|---|
| EX-5.1 - EXHIBIT 5.1 - Cellectar Biosciences, Inc. | tv499409_ex5-1.htm |
| S-1MEF - S-1MEF - Cellectar Biosciences, Inc. | tv499409_s-1mef.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated March 21, 2018, with respect to the consolidated financial statements of Cellectar Biosciences, Inc. and Subsidiary included in the Annual Report on Form 10-K for the years ended December 31, 2017 and 2016, which are incorporated by reference in this Registration Statement on Form S-1 filed pursuant to Rule 462(b) under the Securities Act of 1933. We consent to the incorporation by reference of the aforementioned report in this Registration Statement on Form S-1 filed pursuant to Rule 462(b) under the Securities Act of 1933, and to the use of our name as it appears under the caption "Experts."
/s/ BAKER TILLY VIRCHOW KRAUSE, LLP
Madison, Wisconsin
July 26, 2018